I
mplantable cardioverter defibrillator (ICD) implantation plays an important role in the management of pediatric patients with congenital heart disease (CHD), cardiomyopathy, and channelopathy. Prior studies on outcomes after pediatric ICD implantation have been limited by absolute number of patients, lack of trend analysis, and comparison of characteristics and outcomes with adult patients. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] In a previous study using the National Cardiovascular Data Registry (NCDR) ICD Registry, Jordan et al 1 sought to examine implant and clinical characteristics of pediatric and adult patients with CHD. In this study, they found that among 1601 pediatric patients (≤21 years of age) who underwent ICD placement from 2010 to 2012, only 126 had CHD. The majority of the ICDs in the pediatric cohort were implanted for primary prevention. Comparing pediatric to adult CHD patients, the authors demonstrated similar rate of transvenous device use. Although informative, there has been a considerable expansion of the pediatric population in the NCDR ICD Registry in recent years, with increase in centers performing implants in children. Moreover, no large studies to date have evaluated risk factors associated with complications, reinterventions or comparison of pediatric patient characteristics to the general adult population.
In the present study, we sought to address these gaps in knowledge by studying patient and device characteristics and trends in device implantation among pediatric patients from 2010 to 2016. We evaluated data on both new device implantations as well as early reintervention procedures. Additionally, we analyzed risk factors associated with complications in pediatric device implantation and the requirement for early device intervention.
Finally, we compared these characteristics to the general adult population, which has not been evaluated in a nationally representative sample and has been limited to anecdotal experience.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure. After review by the Institutional Review Board of Cincinnati Children's Hospital Medical Center, need for Institutional Review Board approval and informed consent was waived because of the use of deidentified data.
NCDR ICD Registry
The NCDR ICD Registry is one of the American College of Cardiology Foundation's clinical registries that assists hospitals and private practices to measure and improve quality of care. The ICD Registry is a national standard for understanding treatment patterns, clinical outcome, device safety, and overall quality of care provided to patients with ICD. The registry was initially established in 2005 by the American College of Cardiology Foundation in response to the Centers for Medicare & Medicaid Services mandate for a data collection system that would facilitate coverage with evidence decision for patients covered by Medicare receiving primary prevention ICDs. At present, >1800 hospitals nationwide contribute to the registry with 80% collecting data for all their ICD procedures irrespective of payer or clinical indications.
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Study Population
Data about ICD placement, early generator replacement, and upgrade was collected using V.2.1 of the NCDR ICD Registry data collection form from April 2010 to March 2016. Although the NCDR ICD Registry has included pediatric patients from its inception, pediatric-specific characteristics started to be collected in 2010.
The study focused on characteristics of pediatric patients defined as those who were ≤21 years of age at the time of their first ICD implantation; however, adults (>21 years of age at the time of first ICD implantation) were included for comparison of patient characteristics and device-related complications. An early intervention was defined as a generator replacement/upgrade and initial implant both completed during the study period of 5 years based on the reported median survival of implanted ICDs. 12, 13 Trends in ICD implantation were calculated from 2010 to 2016. Lead only revision were excluded because of a high number of procedures missing lead information.
Variables
Patient demographic and clinical characteristics for the pediatric and adult cohorts were included. Clinical characteristics focused on underlying cardiac pathology (subdivided into 3 broad categories: CHD, cardiomyopathy, syndromes with risk of sudden death), clinical history, diagnostic studies (echocardiography, ECG findings, electrophysiology studies), and medications. Syndromes with risk of sudden death included
WHAT IS KNOWN?
• Implantable cardioverter defibrillator implantation plays an important role in the management of pediatric patients with congenital heart disease, cardiomyopathy, and channelopathy.
• Studies on the outcomes after pediatric implantable cardioverter defibrillator implantation have been limited by the absolute number of patients.
WHAT THE STUDY ADDS?
• There is an increasing trend in implantable cardioverter defibrillator device implantation among pediatric patients.
• Pediatric patients have similar inhospital complication rates compared with adults.
• Lower weight, Ebstein anomaly, worse New York Heart Association class, dual chamber, and cardiac resynchronization therapy-defibrillator were associated with greater risk of complications among pediatric patients.
long QT syndrome, short QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, idiopathic primary ventricular tachycardia/ventricular fibrillation, and others. These were considered to represent channelopathies in the present study. Detailed ICD procedure data including the type of device, defibrillation threshold (DFT) testing, and lead characteristics were also reported. Among those who had generator changes during the study period, procedural implant data was reported. Intra or immediate postprocedural complications and death during the admission for the ICD placement were evaluated.
Comparison Groups
Several cohorts were defined for comparative purposes. Among pediatric patients, this was based on indication (primary versus secondary) for complications and the need for early intervention. General demographic, clinical characteristics, and complications were compared between pediatric and adult patients. Finally, trends in the number of device implantations that occurred during the study period were compared between pediatric and adult patients, classified based on underlying cardiac cause.
Statistical Analysis
Univariate analysis was initially performed to identify differences in the implant characteristics between the patient cohorts. Variables associated with device-related complications and early device intervention were evaluated within the pediatric cohort only. χ 2 test or Fisher's exact test were used for categorical variables, and the t test was used for continuous variables. Multivariable hierarchical logistic and linear regression models were used to examine associations between risk factors and outcomes (complications and premature intervention) among pediatric cohort, respectively. A linear regression model was used to examine the linear trend of ICD implantations from 2010 to 2015. In this model, number of implantations was a response variable, year was a predictor variable and P value of the slope was reported. In this linear regression model, an interaction term was added to test if there was a significant difference in the trend of ICD implantations from 2010 to 2015 between adults and children. The missing rate was low for each variable (<1%). Where missing, we imputed the missing value using the mode for categorical variables and the median value of the nonmissing values for continuous variable. The stepdown Bonferroni-adjusted P value was used to account for multiple comparisons of complications between pediatric and adult patients. The stepwise variable selection method was used to examine risk factors significantly associated with any complications. All analyses were performed on SAS Version 9.4 (SAS Institute Inc., Cary, NC).
RESULTS
Trends in ICD Placement, 2010 to 2016
Over the study time period, there were a total of 565 670 ICD implants of which 3461 (0.6%) were placed in pediatric patients. From 2010 to 2015, there was an overall increase in the incidence of ICD implantations among both pediatric and adult cohorts for both primary and secondary prevention (P<0.05; Figure 1A; Table I in the Data Supplement), with a more prominent increase over time among the adult implant recipients (Table II in the Data Supplement). Examining underlying cause, there was a marked increase in the incidence of device implantations in both adult (P<0.01) and pediatric CHD (P<0.05) patients over time ( Figure 1B ). There was no significant increase in the incidence of ICD implantation for adult or pediatric patients with channelopathies.
Patient Characteristics
The mean age of the pediatric cohort was 13.1 years (±8.0 years) with a predominance of ICD implants placed in white males (73%; Table 1 ). Nonischemic dilated cardiomyopathy was the most common cause for pediatric implantation (39%) followed by hypertrophic cardiomyopathy (17%) and long QT syndrome (13%). The majority of pediatric devices were implanted for primary prevention (60%), and most patients did not have heart failure.
When compared with adult patients, pediatric patients undergoing device placement were more likely to be female, Black race or of Hispanic ethnicity (P<0.0001; Table 1 ). Primary prevention devices accounted for 60% of total devices in the pediatric cohort but were more frequent in the adult cohort accounting for 80% of the devices (P<0.0001; Figure 1A; Table I in the Data Supplement). Although pediatric patients were more likely to have structural heart disease, nonischemic dilated cardiomyopathy, and channelopathies, adult patients predominantly had ischemic heart disease. Compared with the pediatric cohort, adults were more likely to have heart failure (P<0.0001). The predominant device type implanted was single-chamber devices in pediatric patients (55.6%), whereas in adults it was cardiac resynchronization therapy-defibrillator (CRT-D; 36.9%; P<0.0001; Table 1 ). Defibrillation testing was more frequently performed in pediatric than in adult patients (66% versus 56.7%, respectively; P<0.0001).
Comparison of Pediatric Primary and Secondary Prevention Devices
Patients with primary prevention devices were more likely to be younger (mean age, 11.9±8.5 years versus 14.8±6.8 years) than patients who underwent secondary prevention device implants (P<0.0001; Table III in the Data Supplement). Primary prevention devices were more frequently placed for structural heart disease and A, Graph representing increasing primary and secondary prevention device implants in the pediatric population (P<0.05 for each trend). B, Graph demonstrating differences in the underlying primary cause between pediatric and adult patients. (Adults: P<0.01 for all trends except for the channelopathy trend which was 0.1; pediatrics: P<0.05 for CHD, P=0.07 for cardiomyopathy, P=0.4 for ischemic heart disease, and P=0.1 for channelopathy). CHD indicates congenital heart disease. 
Frequency and Types of Complications
When compared with the adult cohort, the pediatric cohort experienced no significant difference in the frequency of complications (2.3% versus 2.6%, P=0.3) or mortality (0.3% versus 0.4%, P=1; (Table 3) .
Early Device Intervention
The mean time to early device intervention with isolated generator replacement, device system failure, or upgrade was shorter in pediatric patients when compared with adult patients (771±629 days versus 979±637 days, P=0.001). However, the frequency of reinterventions was higher in the adult cohort (4.1% versus 3.1%, P=0.001; Figure 2 ). Although battery depletion was the most common generator-specific CRT-D indicates cardiac resynchronization therapy-defibrillator; ICD, implantable cardioverter defibrillator; LET, lowest energy tested; LV, left ventricular; NYHA, New York Heart Association; ULV, upper limit of vulnerability; VF/VFib, ventricular fibrillation; and VT, VTach, ventricular tachycardia. 
DISCUSSION
Pediatric ICD utilization is a growing and vital tool in the management of pediatric patients with indication for implantation, yet the understanding of implantation trends and outcomes has typically been limited to smaller studies. Using the largest national ICD database in the United States, we examined the characteristics of pediatric patients undergoing ICD implantation. The key findings of this study include, first, an overall increasing trend in pediatric device placement for both primary and secondary prevention. Second, the presence of multiple differences in the etiological, clinical, and implant characteristics between the pediatric and adult patients undergoing device implantation. Third, we found a relatively low rate of inhospital complications in pediatrics, which is similar to the rate in the adult cohort. Finally, pediatric patients were less likely than adult patients to require early device intervention though there was a shorter time to intervention when early intervention was required. Although there are clear differences between pediatric and adult ICD cohorts, there is a dearth of studies directly comparing these 2 populations. 2, 3 This study underscores the differences between pediatric and adult populations and renders caution in extrapolation of adult guidelines for pediatric patients. In the present study, pediatric devices accounted for 0.6% of the total ICD implantation in the United States from 2010 to 2016. However, unlike the adult population, in which there is relative homogenous population of those with ischemic disease and nonischemic dilated cardiomyopathy, the pediatric population has a heterogeneous group comprising various structural heart diseases, cardiomyopathies, and channelopathies. This combination of small numbers and heterogeneous cause is the Achilles heel of not only ICD research but pediatric research in general. Not surprisingly, this has resulted in limited research in the field of pediatric ICDs with major guidelines either having adopted adult studies or denote a weak recommendation because of alleged poorer quality evidence. The relatively higher proportion of secondary prevention devices in the pediatric cohort noted in this study could argue for improvements in defining at-risk patients who might qualify for primary prevention devices or could again add evidence to the differences in the substrates between the 2 cohorts. Databases such as the NCDR ICD Registry avail the use of high-quality clinical data to offer an opportunity to gleam into the real-world experience with ICDs.
There is relatively limited data evaluating trends in pediatric ICD placement in large populations. 4, 5 From 1997 to 2006, a series of population-based studies reported a 3-to 4-fold increase in ICD implantation. In the present report, we demonstrate a continuation of this trend, however, the magnitude of this trend from 2010 to 2016 is lower than that reported in the studies from previous years. The cause for the continued increasing trend is likely multifactorial with improved understanding of risk of sudden cardiac death in the pediatric population and improved survival of patients with structural heart disease who later evolve into patients with risk for sudden cardiac death. It is also important to note that there was a slight increase in the number of centers reporting to the registry, which could have also influenced the increasing trend in device placements. The increase in ICD implantation was seen in both primary and secondary prevention with the main etiological contribution being secondary to CHD and to a limited extent by cardiomyopathies. Previous data from the NCDR ICD Registry highlighted the dominance of primary prevention devices in pediatrics, 1 and it appears this trend has continued with primary prevention devices accounting for 60% of all pediatric devices.
Earlier small pediatric studies have demonstrated higher rates of adverse events and poor device survival compared with adult patients.
2,6-10 Pediatric inhospital complications were noted to be high in studies using the Kid's Inpatient Database from 1995 to 2006 (10.0-16.8%) 4, 5 and significantly higher than the adult populations during that time period (2.3-3.4%).
14 Contrary to these studies, the present report from a more robust database demonstrates much lower inhospital complications with rates that are similar to the adult cohort. Technical difficulties in implantation of ICDs likely resulted in more complications in patients with lower weight, Ebstein anomaly, single ventricle patients, and CRT-D. Although it is not surprising that worse New York Heart Association class was associated with complications, the protective effect of β-blockers was interesting. This protective effect could be secondary to a lower frequency of cardiac arrest among patients on β-blockers, which was one of the more frequent complications among pediatric patients. The increased frequency of cardiac arrest and urgent cardiac surgery in the pediatric population could be related to the trends in increased epicardial lead placement in the pediatric population or could be secondary to higher complex CHD pathophysiology in the pediatric population during the postprocedure period unrelated to ICD placement. These pediatric patient-specific risk factors need further studies and need to be included in the discussion of risk-benefits analysis of ICD implantation.
The need for DFT testing remains somewhat controversial secondary to its potential risks. [15] [16] [17] [18] Although a majority of both adult and pediatric patients underwent DFT testing, this was more frequently conducted in the pediatric cohort. Although studies in the adult population have demonstrated the safety of not performing DFT testing, there is a lack of studies specific to the pediatric population. 16, [19] [20] [21] [22] The present report does not show any relationship between DFT testing and inhospital complications in the pediatric population although the relationship requires further assessment.
Finally, although the overall frequency of early device interventions was higher in the adult cohort, when required, the time to early intervention was shorter in the pediatric cohort. Prior smaller studies, but with longer follow-up, have demonstrated a short system survival in the young population and was corroborated by the PLEASE study (Pediatric Lead Extractability and Survival Evaluation) and this current data. 8, 10 We found this to be especially the case in pediatric patients with dual chamber or CRT-D devices which may argue for single-chamber systems when the need for atrial pacing/sensing or biventricular pacing is not clinically needed. However, our study was limited by the absence of lead-specific data, which is the leading cause of early device interventions. The association of nonischemic dilated cardiomyopathy with nongenerator-specific early reinterventions likely represents the frequent need for upgrade to CRT-D in this population.
Limitations
As in any large database study, there are inherent limitations to the findings. Although data quality is subject to reporting errors, the NCDR follows rigorous checks to keep this low. Nonetheless, because of the high number of missing data in lead information, we excluded patients who had lead only revisions, likely underestimating the true number of premature interventions. The reported increase in the number of ICD implants may be influenced by an increase in the number of centers reporting to the NCDR rather than an increase in the volume of patients within each center. Because of the absence of a clear definition of a pediatric center within the registry, we were unable to report the number of pediatric centers. Although it would have been ideal to have data on all system replacements, we were limited to those patients who had their initial device placed between 2010 and 2016. Furthermore, we were unable to clearly discern the temporal occurrence of complications in regard to intraprocedure versus postprocedure complications. Finally, the present study only reports inhospital complications, and we were unable to provide data on 30-day or longer term complications or outcomes for those who did not require ICD interventions.
Conclusions
We reported on the largest national database of pediatric ICDs and demonstrated an increasing trend in pediatric device implantation. The patient and device characteristics of pediatric and adult patients differ significantly. Inhospital complications after pediatric device implantations are rare irrespective of DFT testing, and the rates are comparable to adults. Dual chamber and CRT-D devices, in particular, were found to be associated with increased inhospital complications and decreased system survival.
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